These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35942120)
1. Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization. Sun Z; Quon JL; Papageorgiou CD; Benyahia B; Rielly CD Cryst Growth Des; 2022 Aug; 22(8):4730-4744. PubMed ID: 35942120 [TBL] [Abstract][Full Text] [Related]
2. Preventing Crystal Agglomeration of Pharmaceutical Crystals Using Temperature Cycling and a Novel Membrane Crystallization Procedure for Seed Crystal Generation. Simone E; Othman R; Vladisavljević GT; Nagy ZK Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29364167 [TBL] [Abstract][Full Text] [Related]
3. Application of feedback control and in situ milling to improve particle size and shape in the crystallization of a slow growing needle-like active pharmaceutical ingredient. Yang Y; Pal K; Koswara A; Sun Q; Zhang Y; Quon J; McKeown R; Goss C; Nagy ZK Int J Pharm; 2017 Nov; 533(1):49-61. PubMed ID: 28935256 [TBL] [Abstract][Full Text] [Related]
4. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy. Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455 [TBL] [Abstract][Full Text] [Related]
5. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer. Kshirsagar S; Lakshmi Ramana Susarla N; Ramakrishnan S; Nagy ZK Int J Pharm; 2022 Nov; 627():122172. PubMed ID: 36084877 [TBL] [Abstract][Full Text] [Related]
6. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR. Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557 [TBL] [Abstract][Full Text] [Related]
7. Agglomerative crystallization of ABT-510 in a partially miscible solvent system. Sheikh AY; Pal A; Viswanath S; Tolle JC J Pharm Sci; 2008 Mar; 97(3):1202-12. PubMed ID: 17683060 [TBL] [Abstract][Full Text] [Related]
8. Ultrasound-assisted solution crystallization of fotagliptin benzoate: Process intensification and crystal product optimization. Fang L; Gao Z; Wu S; Jia S; Wang J; Rohani S; Gong J Ultrason Sonochem; 2021 Aug; 76():105634. PubMed ID: 34218067 [TBL] [Abstract][Full Text] [Related]
9. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling. Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272 [TBL] [Abstract][Full Text] [Related]
10. Spherical Crystallization Based on Liquid-Liquid Phase Separation in a Reverse Antisolvent Crystallization Process. Gong W; Li P; Rohani S J Pharm Sci; 2024 Jun; 113(6):1616-1623. PubMed ID: 38311170 [TBL] [Abstract][Full Text] [Related]
12. The use of ultrasound in the crystallization process of an active pharmaceutical ingredient. Belca LM; Ručigaj A; Teslič D; Krajnc M Ultrason Sonochem; 2019 Nov; 58():104642. PubMed ID: 31450288 [TBL] [Abstract][Full Text] [Related]
13. Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients. Watson OL; Jonuzaj S; McGinty J; Sefcik J; Galindo A; Jackson G; Adjiman CS Org Process Res Dev; 2021 May; 25(5):1123-1142. PubMed ID: 34295139 [TBL] [Abstract][Full Text] [Related]
14. Optimization of the Critical Parameters of the Spherical Agglomeration Crystallization Method by the Application of the Quality by Design Approach. Gyulai O; Kovács A; Sovány T; Csóka I; Aigner Z Materials (Basel); 2018 Apr; 11(4):. PubMed ID: 29677152 [TBL] [Abstract][Full Text] [Related]
16. Batch Crystallization of Xylitol by Cooling, Evaporative, and Antisolvent Crystallization. Zaykovskaya A; Louhi-Kultanen M Cryst Growth Des; 2023 Mar; 23(3):1813-1820. PubMed ID: 36879775 [TBL] [Abstract][Full Text] [Related]
17. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization. Murnane D; Marriott C; Martin GP Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448 [TBL] [Abstract][Full Text] [Related]
18. Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions. Meng T; Qiao F; Ma S; Gao T; Li L; Hou Y; Yang J Drug Dev Ind Pharm; 2021 Dec; 47(12):1867-1880. PubMed ID: 35362347 [TBL] [Abstract][Full Text] [Related]
19. New perspectives for the on-line monitoring of pharmaceutical crystallization processes using in situ infrared spectroscopy. Févotte G Int J Pharm; 2002 Jul; 241(2):263-78. PubMed ID: 12100854 [TBL] [Abstract][Full Text] [Related]
20. Crystallization of progesterone for pulmonary drug delivery. Ragab D; Rohani S; Samaha MW; El-Khawas FM; El-Maradny HA J Pharm Sci; 2010 Mar; 99(3):1123-37. PubMed ID: 19691108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]